Loading...
Treatment of Low-Blast Count AML using Hypomethylating Agents
In 2002, the WHO classification reduced the proportion of blasts in the bone marrow (BM) necessary for the diagnosis of acute myeloid leukemia (AML) from 30% to 20%, eliminating the RAEB-t subtype of myelodysplastic syndromes (MDS). However, this AML subtype, defined as low-blast count AML (LBC-AML,...
Saved in:
| Published in: | Mediterr J Hematol Infect Dis |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Università Cattolica del Sacro Cuore
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5499495/ https://ncbi.nlm.nih.gov/pubmed/28698788 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2017.045 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|